RadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD
July 17, 2025
Medical Equipment & Supplies
-
-
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach
July 17, 2025
-
BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations
July 14, 2025
-
NEXGEL and STADA AG Announce Expansion of Partnership for North America
July 14, 2025
-
Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100
July 10, 2025
-
Companion Spine LLC Announces Definitive Agreement to Acquire the Business and Assets of Paradigm Spine GmbH and the Coflex® and CoFix® Spine Implants from Xtant(TM) Medical Holdings, Inc.
July 8, 2025
-
Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework
July 7, 2025
-
ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement
June 27, 2025
-
Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China
May 27, 2025
-
Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials
May 22, 2025
-
Quipt Home Medical Confirms Receipt of Unsolicited Acquisition Proposal
May 21, 2025
-
Catheter Precision, Inc. Completes Acquisition of Cardionomic Heart Failure Assets
May 6, 2025
-
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
April 24, 2025
-
NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
April 23, 2025
-
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure
April 23, 2025
-
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
April 23, 2025